Zydus Life Gets USFDA Nod for Generic Copaxone

💉

has secured FDA approval for its Glatiramer Acetate Injection, the generic version of Copaxone, in both 20 mg/mL and 40 mg/mL strengths. Copaxone recorded $719 million in U.S. sales, marking a major opportunity for Zydus in the neurology segment.